Remicade Relabeling Is Increasing Rate Of TB Screening, J&J Says

Centocor's efforts to increase tuberculosis screening prior to Remicade therapy are working as intended, Johnson & Johnson VP-Investor Relations Helen Short told an Oct. 16 earnings call.